Apothekcon, Inc. an independent medical writing service provider specializing in the pharmaceutical, medical device and allied industries. We have a proven track record with over 100 peer reviewed publications.

THE APOTHEKON MISSION
Our mission is to utilize a broad clinical and scientific background to provide accurate and timely medical writing services that advance our clients goals and objectives.

Dedicated

  • Proven medical and scientific writing skills

Collaborative 

  • Ability to work collaboratively across disciplines to achieve common goals

Experianced

  • Medical communications experience with both professional and public audiences

Proven 

  • Current clients in the pharmaceutical, biotechnology, medical device and related industries
Therapeutic Areas of Expertise
PHARMACEUTICALS 
  • Dermatology
  • Endocrinology
  • Gastroenterology
  • Infectious Disease
  • Neurology
  • Oncology
  • Ophthalmology
  • Sleep Disorders
  • Toxicology
BIOTECHNOLOGY
  • Endocrinology
  • Gastroenterology
  • Metabolic Disease
  • Oncology
MEDICAL DEVICES
  • Cardiology
  • Dermatology
  • Gynecology
  • Infectious Disease
  • Oncology
  • Organ Transplantation
need help?

Let us use our years of experience to help you and your organization.

Expert Services
We provide medical writing services for a variety of clients in the pharmaceutical and medical device industries in the United States, Canada and Europe.
We are capable of providing a broad range of medical writing services including, but not limited to:
  • Investigator Brochures
  • Manuscript Editing & Formatting
  • Newsletters
  • Patient Education Materials
  • Poster Presentations
  • Abstracts
  • Book Chapters
  • Case Reports
  • Clinical Narratives    
  • Clinical Trial Manuscripts
  • Clinical Study Reports
  • Product Monographs
  • Research Manuscripts    
  • Review Articles
  • Standard Response Letters
  • White Papers
All projects completed with professional transparency. Ghost-writing projects not accepted.
 Our Work
Over 100 Peer-reviewed papers, hundreds of abstracts, standard response letters and other medical communications for various clients across the bioscience industries.
View all by expanding the titles to the right.

BioMarin Pharmaceutical – Phenylketonuria

Relative bioavailability of sapropterin from intact and dissolved sapropterin dihydrochloride tablets and the effects of food: a randomized, open-label, crossover study in healthy adults.

View

 

BioMarin Pharmaceutical – Mucopolysaccharidosis

Pharmacodynamics, pharmacokinetics and biodistribution of recombinant human N-acetylgalactosamine 4-sulfatase after 6 months of therapy in cats using different IV infusion durations.

View

QOL Medical, LLC – Sucrase-isomaltase Deficiency

The clinical consequences of sucrase-isomaltase deficiency.

View

 

Variable use of disaccharidase assays when evaluating abdominal pain.

View

Merz

Combined use of microfocused ultrasound and a calcium hydroxylapatite dermal filler for treating atrophic acne scars: a pilot study.

View

Calcium hydroxylapatite combined with microneedling and ascorbic acid is effective for treating stretch marks.

View

Ulthera

Combining microfocused ultrasound with botulinum toxin and temporary and semi-permanent dermal fillers: safety and current use.

View

Multicenter pivotal study of vacuum-assisted precise tissue release for the treatment of cellulite.

View

Erchonia Corporation

Low-level laser therapy for reducing the hip, waist, and upper abdomen circumference of individuals with obesity.

View

A six-week low-level laser therapy protocol is effective for reducing waist, hip, thigh, and upper abdomen circumference.

View

Medicis Pharmaceutical Corporation

Persistence of nasolabial fold correction with a hyaluronic acid dermal filler with retreatment: results of an 18-month extension study.

View

Efficacy and safety of clindamycin phosphate 1.2% and tretinoin 0.025% gel for the treatment of acne and acne-induced post-inflammatory hyperpigmentation in patients with skin of color.

View

Revance Therapeutics

Safety and efficacy of RT002, an injectable botulinum toxin Type A, for treating glabellar lines: results of a phase 1/2, open-label, sequential dose-escalation study.

View

Nonsurgical periorbital and brow rejuvenation.

View

Ferndale Pharma Group, Inc.

Safety and efficacy of oral Polypodium leucotomos extract in healthy adult subjects.

View

Polypodium leucotomos extract: a status report on clinical efficacy and safety.

View

Suneva Medical, Inc.

The psychosocial impact of post-acne scarring.

View

Jazz Pharmaceutical

Extended-release fluvoxamine and improvements in quality of life in patients with obsessive-compulsive disorder.

View

Alexza Pharmaceuticals

The pharmacokinetics and bioavailability of prochlorperazine delivered as a thermally generated aerosol in a single breath to volunteers.

View

BioMarin Pharmaceutical – Lambert-Eaton Myasthenic Syndrome

Genetic variation in aryl N-acetyltransferase results in significant differences in the pharmacokinetic and safety profiles of amifampridine (3,4-diaminopyridine) phosphate.

View

Erchonia Corporation

A retrospective study of non-thermal laser therapy for the treatment of toenail onychomycosis.

View

Anacor Pharmaceuticals, Inc.

Tavaborole for the treatment of onychomycosis.

View

ViraCor-IBT

Cytomegalovirus antiviral resistance: characterization of results from clinical specimens.

View

ViraCor-IBT

Immunosuppression modifications based on an immune response assay: results of a randomized, controlled trial.

View

SARCode

The pharmacologic assessment of a novel lymphocyte function-associated antigen-1 antagonist (SAR 1118) for the treatment of keratoconjunctivitis sicca in dogs.

View

University of California, Davis

Evaluation of the radiographic infrapatellar fat pad sign of the contralateral stifle joint as a risk factor for subsequent contralateral cranial cruciate ligament rupture in dogs with unilateral rupture: 96 cases (2006-2007).

View

Comparison of the tibial mechanical joint orientation angles in dogs with cranial cruciate ligament rupture.

View

 About
Carl-1

Carl S. Hörnfeldt, PhD, RPh

Carl is the president of of Apothekon, Inc. He provides medical information and medical writing expertise with an emphasis on specialty diseases to numerous pharmaceutical, biotechnology and medical device companies. He has written or assisted with the publication of over 100 peer-reviewed manuscripts and hundreds of abstracts, standard response letters and other medical information communications for clients in the fields of oncology, dermatology, neurology, ophthalmology and numerous rare diseases such as narcolepsy and liposomal storage disorders. Carl is a graduate of the University of Minnesota College of Pharmacy and College of Veterinary Medicine and the former Director of Medical Information and Drug Safety at Orphan Medical, Inc.

Professional Experience

Orphan Medical, Inc., Minnetonka, MN, 2000-2005

  • Director, Medical Information and Drug Safety

 

Hennepin Regional Poison Center, Minneapolis, MN 

  • Clinical Coordinator, 1980-2000

Education

University of Minnesota, College of Veterinary Medicine 

  • Doctor of Philosophy, Pharmacology, 1998

 

University of Minnesota, College of Pharmacy 

  • Bachelor of Science, Pharmacy, 1979

 

University of Minnesota, Duluth 

  • Bachelor of Science, Biology, 1976
Contact Us

The Apothekon office is located at The Reserve
724 Bielenberg Drive, Suite 124
Woodbury, MN 55125.